PRESS RELEASE published on 10/21/2024 at 07:30, 1 year 6 months ago Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare Sanofi and CD&R partner to fuel Opella's ambitions in consumer healthcare as Sanofi transfers a 50% stake in Opella. Opella to become a standalone leader backed by Sanofi's strategic support and guidance Partnership Sanofi CD&R Consumer Healthcare Opella
BRIEF published on 10/15/2024 at 22:10, 1 year 6 months ago Sanofi Reports Share and Voting Rights Data for September 2024 Voting Rights Investor Information Sanofi September 2024 Shares Data
BRIEF published on 10/15/2024 at 22:10, 1 year 6 months ago Sanofi publie ses données sur les actions et les droits de vote pour septembre 2024 Droit De Vote Sanofi Informations Pour Les Investisseurs Septembre 2024 Partage Des Données
PRESS RELEASE published on 10/15/2024 at 22:05, 1 year 6 months ago Sanofi: Information concerning the total number of voting rights and shares - September 2024 Sanofi reports total number of voting rights and shares as of September 30, 2024, in compliance with French commercial and stock market regulations Voting Rights French Commercial Code Shares Sanofi Stock Market Authority
PRESS RELEASE published on 10/15/2024 at 22:05, 1 year 6 months ago Sanofi: Informations relatives au nombre de droits de vote et d'actions - SEPTEMBRE 2024 Sanofi communique sur le nombre total de droits de vote et d'actions conformément aux réglementations en vigueur Autorité Des Marchés Financiers Droits De Vote Actions Règlement Général Sanofi
BRIEF published on 10/11/2024 at 08:35, 1 year 6 months ago Sanofi envisage de céder une part majoritaire d'Opella Participations Santé Sanofi CD&R Opella
BRIEF published on 10/11/2024 at 08:35, 1 year 6 months ago Sanofi considers selling majority stake in Opella Participations Health Sanofi CD&R Opella
PRESS RELEASE published on 10/11/2024 at 08:30, 1 year 6 months ago Communiqué de presse : Sanofi en discussions pour céder une participation majoritaire dans Opella Sanofi entame des discussions pour céder une participation majoritaire dans Opella à CD&R. Projet d'indépendance pour Opella aligné avec la stratégie de Sanofi. Opella est un acteur mondial en santé grand public Cession Santé Sanofi CD&R Opella
PRESS RELEASE published on 10/11/2024 at 08:30, 1 year 6 months ago Press Release: Sanofi in discussions to sell a controlling stake in Opella Sanofi is in discussions to sell a controlling stake in Opella, its consumer healthcare business, to CD&R. Opella aims for independence aligning with Sanofi’s focus on innovative medicines and vaccines Negotiations Sale Sanofi Consumer Healthcare Opella
BRIEF published on 10/09/2024 at 07:05, 1 year 6 months ago Sanofi Highlights Beyfortus Effectiveness Against RSV in Infants Sanofi RSV Beyfortus Infants IDWeek 2024
Published on 05/07/2026 at 11:00, 38 minutes ago Kingfisher Metals Announces Fully Funded 2026 Exploration Program
Published on 05/07/2026 at 09:05, 2 hours 33 minutes ago Nano One Appoints Jason Zandberg as Director of Capital Markets
Published on 05/07/2026 at 05:40, 5 hours 58 minutes ago New Horizon Aircraft Ltd. Announces Pricing of $20 Million Offering of Common Shares
Published on 05/07/2026 at 02:00, 9 hours 38 minutes ago Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 12 hours 8 minutes ago Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/07/2026 at 11:15, 22 minutes ago LUYUAN Opens European R&D and Innovation Center in Munich, Anchoring Localization with "China R&D + German Engineering"
Published on 05/07/2026 at 11:00, 37 minutes ago Pylontech Recognized as BloombergNEF Tier 1 Energy Storage Manufacturer
Published on 05/07/2026 at 11:00, 38 minutes ago ABB Ltd: ABB share buybacks - April 30, 2026 - May 6, 2026
Published on 05/07/2026 at 10:45, 53 minutes ago REPLOID secures growth financing in the double-digit million-euro range from Raiffeisen Bank International
Published on 05/07/2026 at 10:35, 1 hour 2 minutes ago Encouraging New Data: Grafalon Benefits High-Risk Pediatric HSCT Patients in the FORUM Study
Published on 05/07/2026 at 07:43, 3 hours 54 minutes ago ENGIE - Information Financière 1er trimestre 2026
Published on 05/06/2026 at 18:00, 17 hours 37 minutes ago Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 17 hours 37 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 17 hours 38 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026